The CEO of a newly formed corporation had only finalized several outsourcing deals to manufacture the MoxaLamp, MoxiMed's main product.
Loading...
The MoxaLamp was built to replace the professional's role in managing a favorite type of conventional Chinese medication treatment, moxibustion. Since the MoxaLamp was prepared for production, the CEO set the proper selling price and must select a target market.
PUBLICATION DATE: April 17, 2014 PRODUCT #: W14110-HCB-ENG
This is just an excerpt. This case is about FINANCE & ACCOUNTING
Related Case Solutions & Analyses:
Alfin Fragrances Inc.
Fighting Childhood Pneumonia in Uganda
Restructuring JAL
Capital Raising and Management – Resorts World Sentosa Singapore
The IPO of Agricultural Bank of China (ABC) (A)
Citibank: Stock Index Insured Account
Multiple Sclerosis Society Of Canada-London-Grand Bend Bicycle Tour
Olympus (A)
Sirius XM Radio Canada
Getting Ready For The Olympic Games
